Taylor Stephanie J C, Candy Bridget, Bryar Rosamund M, Ramsay Jean, Vrijhoef Hubertus J M, Esmond Glenda, Wedzicha Jadwiga A, Griffiths Chris J
Centre for Health Sciences, Barts and The London, Queen Mary's School of Medicine and Dentistry, London E1 2AT.
BMJ. 2005 Sep 3;331(7515):485. doi: 10.1136/bmj.38512.664167.8F. Epub 2005 Aug 10.
To determine the effectiveness of innovations in management of chronic disease involving nurses for patients with chronic obstructive pulmonary disease (COPD).
Systematic review of randomised controlled trials.
24 electronic databases searched for English or Dutch language studies published between January 1980 and January 2005.
Included studies described inpatient, outpatient, and community based interventions for chronic disease management that were led, coordinated, or delivered by nurses. Hospital at home and early discharge schemes for acute exacerbations of COPD were excluded.
We identified nine relevant randomised controlled trials, most of which had some potential methodological flaws. All the interventions seemed to be variations on a case management model. The interventions described could be divided into brief (one month) and longer term (around a year) or more intensive interventions. Only two studies examined the effect of brief interventions, these found little evidence of any benefit. Meta-analysis of the long term interventions failed to detect any influence on mortality at 9-12 months' follow-up (Peto odds ratio 0.85, 95% confidence interval 0.58 to 1.26). There was evidence that the long term interventions had not improved patients' health related quality of life, psychological wellbeing, disability, or pulmonary function. The evidence on whether long term interventions reduced readmissions to hospital was equivocal, but the only study exclusively directed at patients on long term oxygen therapy reported a reduction in readmission. We identified several outcomes where little or no evidence was available; these included patients' satisfaction, self management skills, adherence with treatment recommendations, the likelihood of smoking cessation, and the effect of the interventions on carers.
There is little evidence to date to support the widespread implementation of nurse led management interventions for COPD, but the data are too sparse to exclude any clinically relevant benefit or harm arising from such interventions.
确定涉及护士的慢性病管理创新措施对慢性阻塞性肺疾病(COPD)患者的有效性。
随机对照试验的系统评价。
检索了24个电子数据库,以查找1980年1月至2005年1月期间发表的英文或荷兰语研究。
纳入的研究描述了由护士主导、协调或实施的针对慢性病管理的住院、门诊和社区干预措施。排除了针对COPD急性加重期的居家医院和早期出院方案。
我们确定了9项相关的随机对照试验,其中大多数存在一些潜在的方法学缺陷。所有干预措施似乎都是病例管理模式的变体。所描述的干预措施可分为短期(1个月)、长期(约1年)或更强化的干预措施。只有两项研究考察了短期干预的效果,几乎没有发现任何益处的证据。对长期干预措施的荟萃分析未能在9至12个月的随访中发现对死亡率有任何影响(Peto比值比0.85,95%置信区间0.58至1.26)。有证据表明,长期干预措施并未改善患者的健康相关生活质量、心理健康、残疾状况或肺功能。关于长期干预措施是否减少再次入院的证据不明确,但唯一一项专门针对长期氧疗患者的研究报告再次入院率有所降低。我们确定了几个几乎没有或没有证据的结果;这些结果包括患者满意度、自我管理技能、遵循治疗建议的情况、戒烟的可能性以及干预措施对护理人员的影响。
迄今为止,几乎没有证据支持广泛实施由护士主导的COPD管理干预措施,但数据过于稀少,无法排除此类干预措施产生的任何临床相关益处或危害。